Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
Transoma Medical postpones IPO: Previously planned initial public stock offering worth up to $75 million will be postponed due to "unfavorable market conditions," Transoma Medical says. The St. Paul, Minn.-based firm's Sleuth implantable electrocardiogram monitoring system debuted last October (1"The Gray Sheet" Oct. 22, 2007, p. 16)